Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com
Analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report issued on Wednesday. The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Stock Performance NASDAQ:ADXS traded down $0.02 during midday trading on Wednesday, hitting $1.25. 9,600 shares of the company traded hands, compared to its average […]